Swimming training exacerbates pathological cardiac hypertrophy in kinin B2 receptor-deficient mice

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 271-275

  Batista, Elice C ^a,c   Batista, Eliza C ^b   Ramalho, João D S ^a   Reis, Felipe C G ^a   Barros, Carlos C ^c   Moraes, Milton R ^a,c   Pesquero, Jorge L ^d   Bacurau, Reury F P ^a   Pesquero, João B ^a   Araújo, Ronaldo C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Hypertrophy; Kinin B2 receptor; Swimming

Indexed keywords

BRADYKININ B2 RECEPTOR; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; KALLIKREIN KININ SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWIMMING; TRAINING;

ANIMALS; CARDIOMEGALY; COLLAGEN; EXERTION; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, BRADYKININ B2; RENIN-ANGIOTENSIN SYSTEM; SWIMMING;

EID: 37549045287     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.029     Document Type: Article

References (22)

1. McMullen J.R., and Jennings G.L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 34 (2007) 255-262
2. Emanueli C., and Madeddu P. Role of the kalikrein-kinin system in the maturation of cardiovascular phenotype. Am J Hypertens 12 (1999) 988-989
3. Silva J.A.J.R., Araújo R.C., Baltatu O., Oliveira S.M., Tschope C., Fink E., et al. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with human tissue kallikrein gene. FASEB J 14 (2000) 1858-1860
4. Brull D., Dhamaralt S., Myerson J., Regitz-Zagrosek V., World M., Pennell D., et al. Bradykinin B2BKR receptor polymorphism and left-ventricular response. Lancet 358 (2001) 1155-1156
5. Zuraw B. Bradykinin in protection against left-ventricular hypertrophy. Lancet 358 (2002) 1116-1117
6. 2-receptor knockout mice. Hypertension 32 (1998) 503-509
7. Lorell B.H., and Carabello B.A. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102 (2000) 470-479
8. Evangelista F.S., Brum P.C., and Krieger J.E. Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz J Med Biol Res 12 36 (2003) 1751-1759
9. Taguchi T., Kishikawa H., Motoshima H., Sakai K., Nishiyama T., Yoshizato K., et al. Involvement of bradykinin in acute exercise-induced increase of glucose uptake and translocation in skeletal muscle: studies in normal and diabetic humans and rats. Metabolism 49 (2000) 920-930
10. Moraes M.R., Bacurau R.F.P., Ramalho J.D.S., Reis F.C.G., Casarini D.E., Chagas J.R., et al. Increase in kinins on post-exercise hypotension in normotensive and hypertensive volunteers. Biol Chem 388 5 (2007) 533-540
11. Borges LF, Gutierrez PS, Marana HRC, Taboga SR, Picrosirius-polarization staining method as an efficient histopathological tool for collagenolysis detection in vesical prolapse lesions. Micron, doi:10.1016/j.micron.2006.10.005.
12. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacology 44 (1992) 1-80
13. Pesquero J.B., Araújo R.C., Heppntall P.A., Tucky C.L., Silva J.Á., Walther T., et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci 97 (2000) 8140-8145
14. Araújo R.C., Mori M.A., Merino V.F., Bascands J.L., Schanstra J.P., Zollner R.L., et al. Role of kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem 387 (2006) 431-436
15. Maestri R., Milia A.F., Salis M.B., Graiani G., Lagrasta C., Monica M., et al. Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 41 (2003) 1151-1157
16. Xu J., Carretero O.A., Sun Y., Shesely E.G., Rhaleb N.E., Liu Y.H., et al. Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 45 (2005) 747-753
17. Duka I., Kintsurashvili E., Gavras I., Johns C., Bresnahan M., and Gavras H. Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. Circ Res 88 (2001) 275-281
18. Li H.J., Yin H., Yao Y.Y., Shen B., Bader M., Chao L., et al. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3β activation. Cardiovasc Res 73 (2007) 130-142
19. Zhu Y.C., Zhu Y.Z., Lu N., Wang M.J., Wang Y.X., and Yao T. Role of angiotensina AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodeling. Clin Exp Pharmacol Physiol 30 (2003) 911-918
20. Sakata K., Mochizuki M., Yoshida H., Nawada R., Ohbayashi K., Ishikawa J., et al. Cardiac sympathetic dysfunction contributes to left ventricular remodeling after acute myocardial infarction. Eur J Nucl Med 27 (2000) 1641-1649
21. Shariat-Madar Z., Mahdi F., Warnock M., Homeister J.W., Srikanth S., Krijanovski Y., et al. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood 108 (2006) 192-199
22. Perrino C., Sathyamangla N., Prasad V., Mao L., Noma T., Yan Z., et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116 (2006) 1547-1560